TRIAMCINOLONE (trye-am-sin'oh-lone) Aristocort, Atolone, Kenacort, Kenalog-E TRIAMCINOLONE ACETONIDE Azmacort, Cenocort A2 , Kenalog, Nasacort HFA, Triam-A, Triamonide, Tri-kort, Trilog, Tri-Nasal TRIAMCINOLONE DIACETATE Amcort, Aristocort Forte, Articulose LA, Cenocort Forte, Kenacort, Triam-Forte, Trilone, Tristoject TRIAMCINOLONE HEXACETONIDE Aristospan Classifications: hormones & synthetic substitutes; adrenal corticosteroid; glucocorticoid; antiinflammatory Prototype: Prednisone Pregnancy Category: C |
Triamcinolone 4 mg, 8 mg tablets; 4 mg/5 mL syrup
Triamcinolone acetonide 3 mg/mL, 10 mg/mL, 40 mg/mL injection; 100 mcg aerosol; 55 mcg inhaler; 55 mcg spray; 0.5 mg/mL nasal spray; 0.025%, 0.1%, 0.5% cream, ointment, lotion; 10.3% topical spray
Triamcinolone diacetate 25 mg/mL, 40 mg/mL injection
Triamcinolone hexacetonide 5 mg/mL, 20 mg/mL injection.
Immediate acting synthetic fluorinated adrenal corticosteroid with glucocorticoid and antirheumatic activity 713 times more potent than that of hydrocortisone. Possesses minimal sodium and water retention properties in therapeutic doses.
Antiinflammatory and immunosuppressant drug that is effective in the treatment of bronchial asthma.
An antiinflammatory or immunosuppressant agent. Orally inhaled: bronchial asthma in patient who has not responded to conventional inhalation treatment. Therapeutic doses do not appear to suppress HPA (hypothalamic-pituitary-adrenal) axis.
Safety during pregnancy (category C), lactation, or in children <6 y is not established. Kidney dysfunction; glaucoma. Also see hydrocortisone.
Coagulopathy, hemophilia, diabetes mellitus, GI disease; congestive heart failure; herpes infection; infection; inflammatory bowel disease; myasthenia gravis; MI; ocular exposure, ocular infection; osteoporosis; peptic ulcer disease; PVD; skin abrasion.
Inflammation, Immunosuppression Adult: PO/IM/SC 448 mg/d in divided doses Intraarticular/Intradermal 448 mg/d Inhaled 24 inhalations q.i.d. Topical See Appendix A Child: PO/IM/SC 3.350 mg/m2/d in divided doses Intraarticular/Intradermal 3.350 mg/m2/d Acetonide Adult: IM 60 mg, may repeat with 20100 mg q6wk Intradermal 1 mg per injection site (max: 30 mg total) Intraarticular 2.54.0 mg Inhalation See Appendix A. Child: IM 612 y, 0.030.2 mg q17d Inhalation See Appendix A. Diacetate Adult: PO 448 mg/d in 14 divided doses IM 40 mg once/wk Intradermal 548 mg (max: 75 mg/wk), may repeat q12wk if needed Intraarticular 240 mg q18wk Child: PO 0.1171.66 mg/kg/d Hexacetonide Adult: Intralesional Up to 0.5 mg/in2 of skin Intraarticular 220 mg q34wk |
Assessment & Drug Effects
Patient & Family Education